Fulgent Genetics Files Proxy Materials
Ticker: FLGT · Form: DEFA14A · Filed: Mar 27, 2024 · CIK: 1674930
| Field | Detail |
|---|---|
| Company | Fulgent Genetics, Inc. (FLGT) |
| Form Type | DEFA14A |
| Filed Date | Mar 27, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, sec-filing
Related Tickers: FLGT
TL;DR
Fulgent Genetics (FLGT) filed proxy docs, no fee. Shareholders get info for votes.
AI Summary
Fulgent Genetics, Inc. filed a Definitive Additional Materials proxy statement on March 27, 2024. This filing is related to the company's proxy materials and does not involve a fee, as indicated by the "No fee required" checkbox. The company's principal executive offices are located at 4399 Santa Anita Ave, El Monte, CA 91731.
Why It Matters
This filing provides shareholders with important information regarding the company's governance and upcoming shareholder votes, impacting their investment decisions.
Risk Assessment
Risk Level: low — This is a routine administrative filing related to proxy statements, not a significant event like an acquisition or earnings report.
Key Players & Entities
- Fulgent Genetics, Inc. (company) — Registrant
- 4399 Santa Anita Ave, El Monte, CA 91731 (location) — Business Address
- 0000950170-24-037170 (filing_id) — Accession Number
FAQ
What type of filing is this?
This is a DEFA14A filing, specifically Definitive Additional Materials for a proxy statement.
Who is the filing company?
The filing company is Fulgent Genetics, Inc.
When was this filing made?
The filing was made on March 27, 2024.
Is there a fee associated with this filing?
No, the filing indicates that no fee is required.
What is the company's business address?
The company's business address is 4399 Santa Anita Ave, El Monte, CA 91731.
Filing Stats: 127 words · 1 min read · ~1 pages · Grade level 15.8 · Accepted 2024-03-27 16:07:02
Filing Documents
- 2024_defa_14a-proxy_noti.htm (DEFA14A) — 17KB
- img167497114_0.jpg (GRAPHIC) — 113KB
- img167497114_1.jpg (GRAPHIC) — 89KB
- 0000950170-24-037170.txt ( ) — 296KB
From the Filing
DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant Filed by a Party other than the Registrant Check the appropriate box: Preliminary Proxy Statement Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) Definitive Proxy Statement Definitive Additional Materials Soliciting Material Under Rule 14a-12 FULGENT GENETICS, INC. (Name of Registrant as Specified In Its Charter) (Name of Person(s) Filing Proxy Statement, if Other Than the Registrant) Payment of Filing Fee (Check all boxes that apply): No fee required Fee paid previously with preliminary materials Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11